Literature DB >> 33908477

A PDA-DTC/Cu-MnO2 nanoplatform for MR imaging and multi-therapy for triple-negative breast cancer treatment.

Xiaochun Hu1, Yonglin Lu1, Wenrong Zhao2, Menglin Sun2, Ruihao Li1, Lei Feng1, Tianming Yao1, Chunyan Dong2, Shuo Shi1.   

Abstract

Herein, a multi-functional nanoplatform (PDA-DTC/Cu-MnO2) was established, which has been employed for MR imaging-guided multi-therapy (CDT, PTT and chemotherapy) for cancer treatment. The in vitro and in vivo results confirmed that the biocompatible nanoplatform could significantly induce tumor cell death and inhibit tumor growth.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33908477     DOI: 10.1039/d1cc00987g

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  1 in total

1.  A self-amplified nanocatalytic system for achieving "1 + 1 + 1 > 3" chemodynamic therapy on triple negative breast cancer.

Authors:  Lulu Zhou; Jinjin Chen; Yunhao Sun; Keke Chai; Zhounan Zhu; Chunhui Wang; Mengyao Chen; Wenmei Han; Xiaochun Hu; Ruihao Li; Tianming Yao; Hui Li; Chunyan Dong; Shuo Shi
Journal:  J Nanobiotechnology       Date:  2021-09-04       Impact factor: 9.429

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.